As of 2025-05-14, the Intrinsic Value of Cadila Healthcare Ltd (CADILAHC.NS) is 221.36 INR. This CADILAHC.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 373.90 INR, the upside of Cadila Healthcare Ltd is -40.80%.
The range of the Intrinsic Value is 178.35 - 289.26 INR
Based on its market price of 373.90 INR and our intrinsic valuation, Cadila Healthcare Ltd (CADILAHC.NS) is overvalued by 40.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 178.35 - 289.26 | 221.36 | -40.8% |
| DCF (Growth 10y) | 243.50 - 372.26 | 293.90 | -21.4% |
| DCF (EBITDA 5y) | 420.93 - 689.60 | 538.53 | 44.0% |
| DCF (EBITDA 10y) | 442.16 - 731.51 | 565.99 | 51.4% |
| Fair Value | 121.05 - 121.05 | 121.05 | -67.62% |
| P/E | 497.36 - 1,543.76 | 987.18 | 164.0% |
| EV/EBITDA | 433.85 - 712.13 | 555.30 | 48.5% |
| EPV | 174.70 - 213.53 | 194.11 | -48.1% |
| DDM - Stable | 132.18 - 268.78 | 200.48 | -46.4% |
| DDM - Multi | 195.95 - 297.06 | 235.22 | -37.1% |
| Market Cap (mil) | 382,776.38 |
| Beta | 0.48 |
| Outstanding shares (mil) | 1,023.74 |
| Enterprise Value (mil) | 423,112.38 |
| Market risk premium | 6.92% |
| Cost of Equity | 13.25% |
| Cost of Debt | 8.21% |
| WACC | 12.54% |